DNA MEXC RealStocks
Own real DNA shares through MEXC's regulated brokerage partner.
Suitable for long-term holding.
- Own the actual shares
- Receive dividends and voting rights
- Buy fractional shares starting at $1
Last updated: 2026-11-12 22:19:00. Prices reflect the latest after-hours trading data. Stock price data is sourced from Massive.
Ginkgo Bioworks Holdings, Inc. (DNA) operates in the BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) sector and is listed on NYSE. The stock is currently priced at $10.22, with a market capitalization of $778.55M and a P/E ratio of --. Over the past 52 weeks, its price has ranged from $5.37 to $18.22. This page covers its latest market performance, valuation, price trends and company information.
$778.55M | |
$10.00 | |
$10.46 | |
$9.56 | |
$10.25 | |
2.32M | |
2.42M | |
-- | |
$18.22 | |
$5.37 | |
-- | |
-- |
Ginkgo Bioworks Holdings, Inc. (DNA) is trading at $10.28 in after-hours trading as of 2026-11-12 22:16:00, up 0.63% ($0.06) from the regular-session close of $10.22.
After-hours trading shows how investors are pricing DNA after the regular session closes. The current after-hours price is above the regular-session close, indicating positive after-hours sentiment.
Over the past seven days, Ginkgo Bioworks Holdings, Inc. (DNA) moved from $10.76 to $10.22, representing a decline of 5.05% ($0.54).
The stock traded between $9.56 and $13.12 during the period. The latest price is near the lower end of the 7-day range, indicating strong downward.
The average daily volume was 2.58 million shares, down versus the previous seven-day period, indicating lower trading activity.
Position in Range: 37.7%
DNA is currently trading at $10.22, placing it 37.7% of the way from its 52-week low of $5.37 to its 52-week high of $18.22. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.
Ginkgo Bioworks Holdings Inc is the platform for cell programming, providing flexible, end-to-end services that solve challenges for organizations across diverse markets, from food and agriculture to pharmaceuticals to industrial and specialty chemicals. The Company reorganized its operations into two operating and reportable segments: Cell Engineering engaged in providing biological R&D services for customers across a range of industries and Biosecurity that provides services to government and commercial customers to identify, monitor, prevent, mitigate, and ultimately protect humanity from biological threats. The maximum of revenue is from Cell Engineering Segment.
| Industry | BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) |
| Employees | 485 |
| Exchange | NYSE |
| Company Website |
View the latest dividend and stock split events for Ginkgo Bioworks Holdings, Inc.
Dividend | |
|---|---|
| Ex-Dividend Date | -- |
| Payment Date | -- |
| Dividend Per Share | -- |
Stock Split | |
|---|---|
| Split Date | -- |
| Split Ratio | -- |
Eligible investors can buy real shares of Ginkgo Bioworks Holdings, Inc. (DNA) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.
Stock prices and market data on this page, including price changes and market status, are provided by Massive and other third-party news and data platforms. Market data may be delayed and may differ from prices on other platforms or the prices at which trades are executed on MEXC. MEXC does not guarantee the accuracy, completeness, or timeliness of third-party data. MEXC offers trading products related to DNA, including Stocks, Tokenized Stocks, and Stock Futures.
The stock price information displayed on this page is provided for reference purposes only and may be delayed or differ from real-time market data. Prices, charts, and related metrics do not constitute investment advice and should not be relied upon for trading or investment decisions. MEXC is not responsible for any losses incurred based on the stock price information provided on this page. Please refer to official market sources or consult licensed financial professionals before making any investment decisions.
Estimate the value between DNA shares and USD.
DNA Shares to USD
1.00 DNA shares = 10.217 USD
Calculations are estimates based on the latest available price and are for reference only.